Information meeting – Call for Therapeutic Oligonucleotide Projects at OligoNova Hub / SciLifeLab DDD
April 4 @ 14:00 – 15:00 CEST
The mission of the Drug Discovery and Development Platform at SciLifeLab is to support researchers in developing new drugs, transforming academic ideas into new treatments. Therapeutic oligonucleotides is a recent addition to the Drug Discovery and Development platform’s capacity, available through the OligoNova Hub in Gothenburg.
Now, the first call for therapeutic oligonucleotide projects is opening (March 28 – May 13, 2022).
At this online information meeting, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process.
The call text will be published via the SciLifeLab and OligoNova websites on March 28.
OligoNova Hub is a national facility providing academic researchers in Sweden with support and capabilities to convert ideas and discoveries into potential new oligonucleotide therapies. OligoNova Hub is part of the SciLifeLab Drug Discovery and Development platform, and is located at the AZ BioVentureHub campus in Gothenburg. The OligoNova Hub offers full capacity for the design, synthesis, evaluation and optimization of therapeutic oligonucleotides to academic researchers. The hub has been made possible through support from the Knut and Alice Wallenberg foundation, SciLifeLab, University of Gothenburg, Region Västra Götaland, and a donation from Carl Bennet.